drugset
drugset / Trial / NCT02937857

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

NCT02937857 ↗

Phase 4 Unknown 240 enrolled Jiangxi Qingfeng Pharmaceutical Co. Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicenter, randomized, open Label,add-on study.

Timeline

Start
2016-08
Primary completion
2020-04
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Xiyanping Unknown 0.2 ml Intravenous
Subject Xiyanping Unknown 0.4 ml Intravenous

Indications

bronchitis